LT-3001 (LTT Bio-Pharma)

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameLT-3001 (LTT Bio-Pharma)
Drug Alias NameNSAIDLT-3001 (LTT Bio-Pharma)
ClassificationOther
Mechanisms of ActionPlasminogen activators
TargetsPlasminogen
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLTT Bio-Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLTT Bio-Pharma Co Ltd
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A